Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jun 8;24(1):307.
doi: 10.1186/s13054-020-03010-5.

How I approach weaning from venoarterial ECMO

Justin A Fried  1 , Amirali Masoumi  2 , Koji Takeda  3 , Daniel Brodie  4
Affiliations
Editorial

How I approach weaning from venoarterial ECMO

Justin A Fried et al. Crit Care. .
No abstract available

Keywords: Cardiogenic shock ECMO; ECLS; ECMO weaning; Extracorporeal life support; VA-ECMO weaning; Venoarterial ECMO weaning.

PubMed Disclaimer

Conflict of interest statement

Dr. Brodie receives research support from ALung Technologies; he was previously on their medical advisory board. He has been on the medical advisory boards for Baxter, BREETHE, Xenios, and Hemovent. Dr. Fried, Dr. Masoumi, and Dr. Takeda have no disclosures.

Figures

Fig. 1
Fig. 1
VA-ECMO weaning process. *Criteria required to initiate weaning trial: (1) Phenotype is compatible with recovery (2) End-organ function is improving (3) Pa02/Fi02 > 100 (4) Vasopressors and intropes at low levels (norepinephrine ≤ 4 μg/min, dobutamine < 5 mcg/kg/min) **Any of the following criteria constitutes failure of a weaning trial: (1) MAP falls below 65–70 mmHg or decreases by more than 10 mmHg from baseline (2) Significant increase in intracardiac filling pressures (3) Deterioration in respiratory status
See this image and copyright information in PMC

References

    1. Guglin M, Zucker MJ, Bazan VM, Bozkurt B, El Banayosy A, Estep JD, et al. Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol. 2019;73(6):698–716. doi: 10.1016/j.jacc.2018.11.038. - DOI - PubMed
    1. Cheng YT, Garan AR, Sanchez J, Kurlansky P, Ando M, Cevasco M, et al. Midterm outcomes of bridge-to-recovery patients after short-term mechanical circulatory support. Ann Thorac Surg. 2019;108(2):524–530. doi: 10.1016/j.athoracsur.2019.01.060. - DOI - PubMed
    1. Garan AR, Malick WA, Habal M, Topkara VK, Fried J, Masoumi A, et al. Predictors of survival for patients with acute decompensated heart failure requiring extra-corporeal membrane oxygenation therapy. ASAIO J. 2019;65(8):781–787. doi: 10.1097/MAT.0000000000000898. - DOI - PMC - PubMed
    1. Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246–2256. doi: 10.1093/eurheartj/ehv194. - DOI - PubMed
    1. Garan AR, Eckhardt C, Takeda K, Topkara VK, Clerkin K, Fried J, et al. Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2018;7(8):755–765. doi: 10.1177/2048872617740834. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources